Hereditary Breast Cancer: Part I. Diagnosing Hereditary Breast Cancer Syndromes

No abstract is available for this paper.

• Publication year

  2008

• Venue

  The Breast Journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1524-4741.2007.00515.xPMID 18086272
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HEALTH and HUMAN SERVICES

  2010cited by this paper
• A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

  2007cited by this paper
• Germline Mutations in the BRCA2 Gene and Susceptibility to Hereditary Prostate Cancer

  2007cited by this paper
• Genome-wide association study identifies novel breast cancer susceptibility loci

  2007cited by this paper
• The decrease in breast-cancer incidence in 2003 in the United States.

  2007cited by this paper
• Who should be sent for genetic testing in hereditary colorectal cancer syndromes?

  2007cited by this paper
• Accuracy of BRCA1 and BRCA2 Founder Mutation Analysis in Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue

  2006influential reference
• A genome wide linkage search for breast cancer susceptibility genes

  2006cited by this paper
• Family History, and Impact on Clinical Presentation and Prognosis, in a Population-based Breast Cancer Cohort from the Stockholm County

  2006cited by this paper
• Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

  2006cited by this paper
• Screening for the Lynch syndrome.

  2005cited by this paper
• Genome-wide scanning for linkage in Finnish breast cancer families

  2004cited by this paper
• Genome-wide scanning for linkage in Finnish breast cancer families

  2004cited by this paper
• A novel founder CHEK2 mutation is associated with increased prostate cancer risk.

  2004cited by this paper
• Cancer risk assessment: quality and impact of the family history interview.

  2004cited by this paper
• The family history--more important than ever.

  2004cited by this paper
• CHEK2 is a multiorgan cancer susceptibility gene.

  2004cited by this paper
• The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype.

  2003cited by this paper
• Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects

  2003cited by this paper
• An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer

  2003cited by this paper
• Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist.

  2003cited by this paper
• A clinical, histopathological, and genetic study of Avellino corneal dystrophy in British families

  2003cited by this paper
• Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

  2002cited by this paper
• Cost-Effectiveness of Microsatellite Instability Screening as a Method for Detecting Hereditary Nonpolyposis Colorectal Cancer

  2001cited by this paper
• Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

  2001cited by this paper
• Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.

  2001cited by this paper
• Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

  2001cited by this paper
• Family information service and hereditary cancer

  2001cited by this paper
• Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations.

  2000cited by this paper
• Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.

  1999cited by this paper
• Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.

  1998cited by this paper
• Familial breast-ovarian cancer locus on chromosome 17q12-q23.

  1991cited by this paper
• Linkage of early-onset familial breast cancer to chromosome 17q21.

  1990cited by this paper
• Breast cancer genetics in an oncology clinic: 328 consecutive patients.

  1986cited by this paper
• Genetic and pathologic findings in a kindred with hereditary sarcoma breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma

  1978cited by this paper
• Familial association of carcinoma of the breast and ovary.

  1974cited by this paper
• Tumor variation in families with breast cancer.

  1972cited by this paper

• Abbreviated Breast MRI as a Supplement to Mammography in Family Risk History of Breast Cancer within the Croatian National Breast Screening Program

  2024cites this paper
• Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study

  2023cites this paper
• Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese Population

  2021cites this paper
• A Review of Breast Cancer Risk Factors in Adolescents and Young Adults

  2021cites this paper
• The role of microbial pathogens in cancer development: a potential guide to anticancer drugs

  2020cites this paper
• How to manage BRCA mutation carriers?

  2020cites this paper
• Diagnostic yield of a custom-designed multi-gene cancer panel in Irish patients with breast cancer

  2020cites this paper
• Oncology Advanced Practitioners and Breast Cancer Prevention

  2020cites this paper
• Exome Sequencing in BRCA1- and BRCA2-Negative Greek Families Identifies MDM1 and NBEAL1 as Candidate Risk Genes for Hereditary Breast Cancer

  2019cites this paper
• Estudo das vias de sinalização envolvidas na apoptose induzida pelo complexo de rutênio com timina em células de carcinoma de cólon humano HCT116

  2019cites this paper
• Comparison of the Diagnostic Accuracy of Next Generation Sequencing and Microarray Resequencing Methods for Detection of BRCA1 and BRCA2 Gene Mutations

  2018cites this paper
• Exploring Ob-Gyn providers' experience with and knowledge of multi-gene panels for hereditary breast and ovarian cancer

  2018cites this paper
• Aberrant promoter methylation of PCDH10 as a potential diagnostic and prognostic biomarker for patients with breast cancer

  2018cites this paper
• Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients

  2017cites this paper
• Breast and ovarian cancer referrals to the ACT Genetic Service: are we meeting guidelines?

  2017cites this paper
• BSO versus GnRH analogue: cost-effectiveness evaluation

  2017cites this paper
• Adaptation of the Genetic Risk Prediction Model BRCAPRO for Primary Care Settings

  2017cites this paper
• Our genes, our selves: hereditary breast cancer and biological citizenship in Norway

  2017cites this paper
• Does obesity modify the relationship between physical activity and breast cancer risk?

  2017cites this paper
• Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis.

  2017cites this paper
• Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and Treatment

  2017cites this paper
• Consultations d’oncogénétique pédiatrique : Quelles indications et quelles pratiques dans un service spécialisé de cancérologie pédiatrique ? Enquête dans le centre spécialisé du CHU de Bordeaux en 2011–2012

  2016cites this paper
• Our genes, our selves: hereditary breast cancer and biological citizenship in Norway

  2016cites this paper
• F344/NTac Rats Chronically Exposed to Bromodichloroacetic Acid Develop Mammary Adenocarcinomas With Mixed Luminal/Basal Phenotype and Tgfβ Dysregulation

  2016cites this paper
• Glutathione S-transferase P1 rs1695 A>G polymorphism and breast cancer risk: evidence from a meta-analysis.

  2016cites this paper
• Cancer risk variation in BRCA1/2 mutation families

  2016cites this paper
• Routine use of gene panel testing in hereditary breast cancer should be performed with caution.

  2016cites this paper
• THE ROLE AND REGULATION of MITOCHONDRIAL DYNAMICS IN CISPLATIN RESISTANCE IN HUMAN GYNECOLOGIC CANCER CELLS

  2015cites this paper
• Prevalence, clinical characteristics, and risk factors for breast cancer in asymptomatic adults

  2015cites this paper
• Environmental and DNA repair risk factors for breast cancer in South China.

  2015cites this paper
• Understanding the functions of the novel oncogene SHON in breast cancer

  2015cites this paper
• Quelles indications et quelles pratiques dans un service spécialisé de cancérologie pédiatrique

  2014cites this paper
• Analysis of novel mutations in BRCA1 in Iranian families with breast cancer.

  2014cites this paper
• Association of BRCA2 variants with cardiovascular disease in Saudi Arabia.

  2014cites this paper
• BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling

  2014cites this paper
• Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer

  2014cites this paper
• Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models.

  2014cites this paper
• Hereditary breast cancer

  2014cites this paper
• Risk of second primary cancer after breast cancer treatment.

  2014cites this paper
• The Implications of JK-1(FAM134B) Gene in Human Cancer

  2014influential citation
• Methylation of BRCA1 Promoter Region Is Associated with Unfavorable Prognosis in Women with Early-Stage Breast Cancer

  2013cites this paper
• Polymorphisms of catechol estrogens metabolism pathway genes and breast cancer risk in Mexican women.

  2013cites this paper
• Epigenome-wide association study of breast cancer using prospectively collected sister study samples.

  2013cites this paper
• Declining second primary ovarian cancer after first primary breast cancer.

  2013cites this paper
• Risk assessment for breast cancer and BRCA mutations in women with personal and familial history

  2013cites this paper
• Epidemiology and Etiology of Breast Cancer

  2013cites this paper
• Place du médecin généraliste dans la prise en charge des personnes génétiquement prédisposées aux cancers

  2013cites this paper
• Chapter 149 – Skin Cancer

  2013cites this paper
• Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer

  2012cites this paper
• BRCA2 Variants and cardiovascular disease in a multi-ethnic study

  2012cites this paper
• Novel insight into the regulation of steroid hormone receptor signaling by protein arginine methyltransferase 6 and regulation of TRIM22 expression in breast cancer

  2012cites this paper
• Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: Evidence that they exert tumoricidal effects via tumor tropism

  2012influential citation
• Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families

  2012cites this paper
• Original Research: Being Young, Female, and BRCA Positive

  2012cites this paper
• Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing

  2012cites this paper
• Advances in membrane proteomics and cancer biomarker discovery: Current status and future perspective

  2012cites this paper
• Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms

  2012cites this paper
• A two-stage exploratory study of the coping patterns of Arab women with breast cancer residing in the United Arab Emirates

  2011cites this paper
• Biomarkers in Breast Cancer

  2011cites this paper
• Targeting FOXO3a and sirtuins in breast cancer

  2011cites this paper
• Modulation of Hemostatic Pathways by Breast Cancer Chemotherapy Agents

  2011cites this paper
• Avaliação da patogenicidade de mutações germinativas de significado desconhecido nos genes BRCA1 e BRCA2 em famílias portuguesas.

  2011cites this paper
• Breast Cancer Risk Assessment Using the OncoVue® Model

  2011cites this paper
• Prophylactic, Risk-Reducing Surgery in Unaffected BRCA-Positive Women: Quality Of Life, Sexual Functioning and Psychological Well-Being

  2011cites this paper
• Poly(ADP-Ribose) Polymerase-1 Inhibition: Preclinical and Clinical Development of Synthetic Lethality

  2011cites this paper
• Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions.

  2011cites this paper
• PEDIGREE ANALYSIS OF PATIENTS WITH THERAPY-RELATED MYELOID NEOPLASMS REVEALS GERM-LINE MUTATIONS IN THE DNA DAMAGE RESPONSE GENES BRCA1, BARD1 AND TP53

  2011influential citation
• Association of a functional polymorphism (Gln261Arg) in 12-lipoxygenase with breast cancer.

  2011cites this paper
• Magnetic Resonance Imaging (MRI) in the Screening of High-Risk Patients and in the Detection and Diagnosis of Early Breast Cancer

  2011cites this paper
• Inherited Cancer Syndromes in Children and Young Adults

  2010cites this paper
• BRCA gene testing in a woman with a family history of cancer

  2010influential citation
• Breast Cancer Epidemiology

  2010cites this paper
• Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions

  2010cites this paper
• FACULDADE DE CIÊNCIAS FARMACÊUTICAS Programa de Pós-Graduação em Ciência dos Alimentos Área de Nutrição Experimental Ausência de atividade quimiopreventiva por parte da vitamina A quando administrada a ratas na etapa de pós-iniciação da carcinogênese mamária

  2010cites this paper
• The Biology of Breast Cancer

  2010cites this paper
• Retrospective comparison of patient outcomes after in-person and telephone results disclosure counseling for BRCA1/2 genetic testing

  2010cites this paper
• BRCA 1 and BRCA 2 : Cancer Risk and Genetic Testing

  2010cites this paper
• Head circumference in the clinical detection of PTEN hamartoma tumor syndrome in a clinic population at high-risk of breast cancer

  2010influential citation
• Detection of BRCA1 and BRCA2 Ashkenazi Jewish founder mutations in formalin-fixed paraffin-embedded tissues using conventional PCR and heteroduplex/amplicon size differences.

  2010cites this paper
• High-throughput resequencing in the diagnosis of BRCA1/2 mutations using oligonucleotide resequencing microarrays

  2010influential citation
• ¿Sabemos qué causa el cáncer de mama? Influencia actual de los diferentes factores de riesgo

  2009cites this paper
• Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers.

  2009cites this paper
• New series No 1271

  2009cites this paper
• Breast cancer risk elements and nurse practitioners' knowledge, use, and perceived comfort level of breast cancer risk assessment

  2009cites this paper
• Hereditary Breast Cancer and Hereditary Non-Polyposis Colorectal Cancer: Description of Two Families, as the Examples of Classical Hereditary Predisposition to Cancers

  2009cites this paper
• Studies of LRIG1 and the ERBB receptor family in breast and colorectal cancer

  2009cites this paper
• Genetic issues in patients with breast cancer.

  2009cites this paper
• Hereditary breast cancer: new genetic developments, new therapeutic avenues

  2008cites this paper
• Population Prevalence of First-Degree Family History of Breast and Ovarian Cancer in the United States: Implications for Genetic Testing§

  2008cites this paper
• Hereditary diffuse gastric cancer: prophylactic surgical oncology implications.

  2008cites this paper
• Análise da expressão de RNAs não-codificadores intrônicos em tumores de mama

  2008cites this paper
• Breast cancer: Molecular basis and therapeutic strategies (Review).

  2008cites this paper
• Molecular diagnosis in oncology

  2008cites this paper
• Molecular pathology--translating research into clinical practice: an expanding frontier in surgical oncology.

  2008cites this paper
• epigenome-wide Association Study of Breast cancer Using Prospectively collected Sister Study Samples

  year unknowncites this paper
• epigenome-wide Association Study of Breast cancer Using Prospectively collected Sister Study Samples

  year unknowncites this paper
• Breast and gynecologic hereditary cancer

  year unknowncites this paper